Find Press / Media

Search results

• ViralClear Publishes in F1000 Research In Vitro Data Demonstrating Synergy between Merimepodib and Remdesivir Against SARS CoV 2, the Cause of COVID 19

  Cheng Huang & Slobodan Paessler

  5/14/20

  2 items of Media coverage

  Press/Media: Expert Comment

• ViralClear Publishes in F1000 Research In Vitro Data Demonstrating Synergy between Merimepodib and Remdesivir Against SARS-CoV-2, the Cause of COVID-19

  Cheng Huang & Slobodan Paessler

  5/14/20

  16 items of Media coverage

  Press/Media: Expert Comment

• Galveston County and UTMB to Open Mass COVID-19 Testing

  Benny Raimer

  5/15/20

  3 items of Media coverage

  Press/Media: Expert Comment

• Rice Engineer Wins Grant to Study Temperature and Coronavirus

  Chien-Te Tseng

  5/14/20 → 5/15/20

  4 items of Media coverage

  Press/Media: Expert Comment

• Free mass COVID-19 testing to return to Galveston County

  Benny Raimer & Philip Keiser

  5/16/20

  1 item of Media coverage

  Press/Media: Expert Comment

• Before you go back out in public, read the immunity checklist

  Rizwana Sultana

  5/18/20

  1 item of Media coverage

  Press/Media: Expert Comment

• BioSig Technologies: FDA Clears the Investigational New Drug Application to Enable the Phase II Trial of ViralClear's Merimepodib, Oral Solution to Treat Adult Patients with Advanced COVID-19, to Proceed

  Cheng Huang & Slobodan Paessler

  5/18/20

  1 item of Media coverage

  Press/Media: Expert Comment

• FDA Clears the Investigational New Drug Application to Enable the Phase II Trial of ViralClear's Merimepodib, Oral Solution to Treat Adult Patients with Advanced COVID-19, to Proceed Nasdaq:BSGM

  Cheng Huang & Slobodan Paessler

  5/18/20

  13 items of Media coverage

  Press/Media: Expert Comment

• Galveston County, UTMB to open free test sites

  Benny Raimer & Philip Keiser

  5/18/20

  1 item of Media coverage

  Press/Media: Expert Comment

• Libraries capture local history of COVID-19 crisis

  Tammy Cupit

  5/18/20

  1 item of Media coverage

  Press/Media: Expert Comment

• BioSig Technologies: ViralClear Closes $10.8 Million Equity Financing for Development of COVID-19 Broad-Spectrum Oral Anti-Viral Candidate Merimepodib

  Cheng Huang & Slobodan Paessler

  5/20/20

  1 item of Media coverage

  Press/Media: Expert Comment

• ViralClear Closes $10.8 Million Equity Financing for Development of COVID-19 Broad-Spectrum Oral Anti-Viral Candidate Merimepodib

  Cheng Huang & Slobodan Paessler

  5/20/20

  18 items of Media coverage

  Press/Media: Expert Comment

• Atomwise Partners with Global Research Teams to Pursue Broad-Spectrum Treatments Against COVID-19 and Future Coronavirus Outbreaks

  Alexander Freiberg

  5/20/20 → 5/21/20

  26 items of Media coverage

  Press/Media: Expert Comment

• Community health; Before you go back out in public, read the immunity checklist; Guidelines put focus on taking a common-sense approach to diet, exercise, sleep and overall wellness

  Rizwana Sultana

  5/21/20

  1 item of Media coverage

  Press/Media: Expert Comment

• Before you go back out in public, read the immunity checklist; Guidelines on taking a common-sense approach to diet, exercise, sleep and overall wellness

  Rizwana Sultana

  5/27/20

  4 items of Media coverage

  Press/Media: Expert Comment

• Before you go back out in public, read the immunity checklist; Guidelines put focus on taking a common-sense approach to diet, exercise, sleep and overall wellness

  Rizwana Sultana

  5/27/20

  2 items of Media coverage

  Press/Media: Expert Comment

• La Marque man recovering after 51 days in the hospital fighting COVID-19

  Shawn Nishi

  5/27/20

  1 item of Media coverage

  Press/Media: Expert Comment

• Michael R. Dougherty Joins The Board Of ViralClear Pharmaceuticals, A Majority-owned Subsidiary Of BioSig Technologies, Inc.

  Cheng Huang & Slobodan Paessler

  5/28/20

  20 items of Media coverage

  Press/Media: Expert Comment

• Atomwise Updates on Research Collaborations

  Alexander Freiberg

  5/28/20 → 5/31/20

  2 items of Media coverage

  Press/Media: Expert Comment

• Atomwise Reports Research Collaborations

  Alexander Freiberg

  5/30/20 → 6/1/20

  2 items of Media coverage

  Press/Media: Expert Comment

• Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States.(RESEARCH)

  Shinji Makino, Steven Widen & Kenneth Plante

  6/1/20

  1 item of Media coverage

  Press/Media: Expert Comment

• ViralClear To Host Conference Call On June 9th To Discuss Upcoming And Recent Developments For Phase II Human Clinical Trials Of Its Broad-Spectrum Oral Anti-viral Candidate For Treatment Of COVID-19

  Cheng Huang & Slobodan Paessler

  6/1/20

  14 items of Media coverage

  Press/Media: Expert Comment

• Atomwise Reports Partnerships with Global Research Teams

  Alexander Freiberg

  5/31/20 → 6/3/20

  2 items of Media coverage

  Press/Media: Expert Comment

• BioSig Technologies Expands Intellectual Property Portfolio

  Cheng Huang & Slobodan Paessler

  6/3/20

  22 items of Media coverage

  Press/Media: Expert Comment

• Atomwise Updates on Partnerships with Global Research Teams

  Alexander Freiberg

  5/29/20 → 6/4/20

  3 items of Media coverage

  Press/Media: Expert Comment